Gilead Sciences, Inc. - Stock Analysis

Drug Manufacturers - General
Healthcare

Gilead Sciences, Inc.

GILD · US · NASDAQ

75.59

USD

+1.59

(2.10%)

0.39

EPS
194.75

P/E
94.2B

MARKET CAP
4.02%

DIV YIELD

Ten CAP valuation

Operating Cash Flow

$

Capital Expenditures

$

% for Maintenance

%

Maintenance CapEx

$

Tax Provision

$

Shares Outstanding

#

Owner Earnings

$

Owner Earnings per Share

$

--

Margin Of Safety valuation

Current EPS

$

Future Growth Rate

%

Future PE

Minimum Accepatable Rate Of Return

%

Sticker Price:

--

MOS Price:

--